Milestone Pharmaceuticals Inc. Proceeds from Issuance or Sale of Equity
Milestone Pharmaceuticals Inc. (MIST) had Proceeds from Issuance or Sale of Equity of $48.60 million as of 2025-07-11, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2026-08-12
- 2025-07-11: Proceeds from Issuance or Sale of Equity $48.60M.
- 2020-07-29: Proceeds from Issuance or Sale of Equity $50.00M.
| Period end | Proceeds from Issuance or Sale of Equity |
|---|---|
| 2025-07-11 | $48.60M 10-Q · filed 2026-08-12 |
| 2020-07-29 | $50.00M 10-Q · filed 2026-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B |